StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.00−0.02 (-0.66%)

Close on Nov 17, 2026Market cap $519.43MP/E –Yield –

Entera Bio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Entera Bio's pe ratio was 3.4× on Jan 31, 2022, against 1.6× a year earlier. Over the last 4 years it ranged from 1.2× to 8.9×, with a median of 2.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 20223.4×−0.8
2021Dec 31, 20214.2×+3.0
2020Dec 31, 20201.2×−0.4
2019Dec 31, 20191.6×+0.4
2018Dec 31, 20181.2×–

More Entera Bio figures

See a number that looks wrong?